NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 734631 | Null | 0.0438391811600412 | 0.25820546 |
NSC 736780 | (2Z,4E)-2-cyano-5-[4-(diethylamino)phenyl]penta-2,4-dienethi oamide | 0.0438391811600412 | 0.36496107 |
NSC 743874 | Null | 0.0438391811600412 | 0.37830926 |
NSC 744469 | 3-cyano-3,3-diphenylpropyl 4-(3-[(11aS)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypropyl)-1-piperazinecarbodithioate | 0.0438391811600412 | 0.26187192 |
NSC 750685 | Null | 0.0438391811600412 | 0.39562621 |
NSC 76150 | Null | 0.0438391811600412 | 0.52437971 |
NSC 90810 | Null | 0.0438391811600412 | 0.44325131 |
NSC 95466 | PCNU | 0.0438391811600412 | 0.11103203 |
NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0438391811600418 | 0.4227003 |
NSC 133118 | 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) | 0.0438391811600418 | 0.074160364 |